Kalijev Klorid B. Braun

Potassium Chloride, the active ingredient in Kalijev Klorid B. Braun, is an electrolyte (potassium salt) presented as an injection solution for intravenous use. It corrects low blood potassium levels and supports normal cellular function in patients who require potassium replenishment.

GNH USA supplies Kalijev Klorid B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kalijev Klorid B. Braun is used in clinical situations that involve potassium deficiency or the need for electrolyte replacement.

- Hypokalemia: restores normal serum potassium concentrations in patients with low potassium levels. - Potassium supplementation: provides supplemental potassium for patients on diuretics or other potassium‑depleting therapies. - Electrolyte replacement therapy: maintains electrolyte balance during surgery, critical care, or severe fluid loss.

Kalijev Klorid B. Braun may be associated with a range of adverse reactions, most of which are related to the rapid rise in serum potassium or the intravenous route.

Common Side Effects: - Mild vein irritation or pain at the injection site. - Transient nausea or vomiting. - Temporary headache. - Low‑grade fever. - Mild electrolyte imbalance other than potassium.

Serious or Rare Side Effects: - Hyperkalemia leading to cardiac arrhythmia. - Severe allergic reaction (anaphylaxis). - Phlebitis or thrombophlebitis. - Rapid rise in serum potassium causing muscle weakness. - Cardiac arrest in extreme cases.

When using Kalijev Klorid B. Braun, clinicians should observe several safety measures to minimize risk.

- Assess serum potassium: verify baseline levels before administration. - Adjust dose in renal impairment: reduce or monitor closely. - Avoid rapid infusion: follow recommended infusion rates to prevent hyperkalemia. - Monitor cardiac function: continuous ECG monitoring in high‑risk patients. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potassium Chloride can interact with several medications, altering potassium balance or cardiac risk.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may cause additive hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of dangerous potassium elevation. - Digoxin: heightened risk of digoxin toxicity with high potassium.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can reduce renal potassium excretion. - Beta‑blockers: may mask symptoms of hyperkalemia. - Insulin or glucose therapy: can shift potassium intracellularly, affecting serum levels.